# CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

> **NCT00245401** · PHASE4 · COMPLETED · sponsor: **Cordis US Corp.** · enrollment: 2070 (—)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** CYPHERTM Sirolimus-Eluting Coronary Stent

## Key facts

- **NCT ID:** NCT00245401
- **Lead sponsor:** Cordis US Corp.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2004-12
- **Target enrollment:** 2070 (—)
- **Last updated:** 2007-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00245401

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00245401, "CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)". Retrieved via MORVS 2026-10-18 from https://api.morvs.ai/clinical/NCT00245401. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*